hepat
e
viru
hev
increasingli
recognis
major
caus
acut
hepat
worldwid
viru
annual
respons
million
infect
million
symptomat
case
death
mainli
occur
less
develop
region
world
debe
moradpour
neyt
gouttenoir
although
infect
hev
usual
sever
form
chronic
infect
describ
mainli
immunocompromis
patient
high
rate
mortal
also
report
among
pregnant
women
addit
hev
infect
associ
broad
rang
extrahepat
manifest
includ
renal
injuri
varieti
neurolog
disord
kamar
marion
abravanel
izopet
dalton
four
genotyp
gt
pathogen
human
exclus
infect
human
wherea
zoonot
mainli
infect
mammal
occasion
transmiss
human
doceul
bagdassarian
demang
pavio
industrialis
countri
common
genotyp
caus
hev
infect
importantli
due
evolut
toward
chronic
immunocompromis
infect
patient
hev
transmiss
blood
transfus
resist
infect
patient
ribavirin
complic
patient
preexist
liver
diseas
hev
infect
consid
emerg
problem
industrialis
countri
say
vercout
abdelwahab
vercauteren
meuleman
hev
classifi
sole
member
orthohepeviru
genu
within
hepevirida
famili
smith
et
al
viru
contain
linear
rna
genom
encod
three
open
read
frame
orf
name
tam
et
al
largest
gene
encod
polyprotein
protein
contain
sever
function
domain
essenti
viral
replic
koonin
et
al
function
domain
includ
methyltransferas
met
cystein
proteas
rna
helicas
hel
rna
polymeras
review
debe
et
al
date
clear
evid
protein
process
proteas
antibodi
robustli
recognis
protein
avail
encod
viral
capsid
protein
involv
particl
assembl
bind
host
cell
elicit
neutralis
antibodi
recent
demonstr
lifecycl
hev
produc
three
form
capsid
protein
infectiousintracellular
glycosyl
cleav
protein
associ
infecti
particl
wherea
protein
massiv
produc
glycoprotein
associ
infecti
particl
major
antigen
present
patient
sera
montpelli
et
al
encod
small
multifunct
phosphoprotein
involv
virion
morphogenesi
egress
review
holla
ahmad
ahmad
jameel
due
difficulti
effici
propag
hev
cell
cultur
numer
pathway
process
hev
lifecycl
remain
elucid
notabl
mechan
lead
hev
replic
particularli
poorli
understood
howev
shown
protein
might
localis
endoplasm
intermedi
compart
ergic
suggest
hev
replic
might
occur
within
earli
secretori
pathway
spuul
ahola
rna
viru
replic
occur
close
associ
host
cell
membran
infect
cell
cellular
viral
factor
cooper
gener
particular
structur
resembl
organel
name
viral
replic
factori
compartmentalis
allow
coordin
differ
step
replic
cycl
highli
effici
rna
replic
protect
viral
genom
cell
defenc
mechan
note
number
virus
viral
bud
site
locat
near
replic
factori
indic
spatial
coordin
replic
viral
assembl
step
induc
massiv
membran
rearrang
virus
use
cellular
factor
activ
membran
exploit
cellular
pathway
involv
membran
homeostasi
review
paul
particular
virus
divert
compon
cellular
secretori
pathway
inde
shown
laboratori
guanin
factor
golgi
brefeldin
bfa
resist
factor
necessari
hepat
c
viru
hcv
replic
farhat
et
al
goueslain
et
al
also
identifi
cellular
factor
essenti
replic
number
virus
picornavirus
coronavirus
belov
feng
nikov
jackson
ehrenfeld
lank
et
al
van
der
linden
van
der
schaar
lank
neyt
van
kuppeveld
verheij
et
al
investig
hev
replic
mechan
use
bfa
fungal
metabolit
inhibit
activ
arf
protein
small
regul
cellular
secretori
pathway
inact
cytoplasm
form
arf
protein
upon
nucleotid
exchang
gtp
undergo
conform
chang
allow
protein
bind
membran
activ
form
arf
protein
essenti
format
secretori
vesicl
actin
remodel
phospholipid
metabol
recruit
membran
effector
mediat
process
bfa
block
arf
activ
inhibit
subset
guanin
nucleotid
exchang
factor
gef
regul
convers
human
cell
bfa
inhibit
function
three
known
arf
gef
stabilis
normal
transient
complex
form
gef
demonstr
bfa
inhibit
hev
replic
identifi
gef
requir
hev
replic
order
investig
role
cellular
membran
hev
infect
use
bfa
block
sever
membran
traffick
pathway
caus
major
membran
rearrang
host
cell
klausner
donaldson
gaussia
luciferas
gluc
subgenom
replicon
construct
deriv
hev
strain
modifi
produc
subgenom
replicon
replicon
first
amino
acid
match
signal
peptid
gaussia
luciferas
delet
block
secret
luciferas
context
amount
intracellular
gluc
proport
viral
rna
synthesi
consequ
hev
replic
addit
system
allow
replic
monitor
independ
protein
secret
block
bfa
cell
electropor
rna
luciferas
activ
measur
hr
pe
time
point
valu
present
fold
increas
compar
luciferas
activ
measur
hr
pe
shown
figur
level
steadili
increas
time
reach
fold
increas
time
hr
pe
indic
replicon
effici
replic
cell
use
tool
studi
hev
replic
step
cell
treat
hr
differ
concentr
bfa
figur
parallel
transfect
cell
treat
sofosbuvir
inhibitor
hcv
polymeras
recent
describ
hev
replic
inhibitor
dao
thi
et
al
figur
luciferas
activ
measur
hr
pe
bfa
concentr
valu
present
percentag
replic
compar
cell
dimethyl
sulfoxid
dmso
expect
treatment
cell
sofosbuvir
led
decreas
hev
replic
inhibitori
concentr
interestingli
treatment
electropor
cell
bfa
also
led
decreas
hev
replic
figur
indic
bfa
inhibitor
hev
replic
next
verifi
decreas
hev
replic
due
toxic
effect
bfa
treatment
perform
viabil
assay
cell
treat
hr
bfa
shown
figur
although
weak
toxic
observ
concentr
hev
replic
reduc
log
signific
toxic
effect
indic
inhibitori
effect
bfa
hev
replic
due
cell
toxic
order
confirm
inhibitori
effect
bfa
hev
replic
anoth
cell
line
next
analys
bfa
activ
hev
replic
cell
deriv
cell
clone
highli
replic
hev
genom
montpelli
et
al
figur
shown
figur
bfa
effici
inhibit
replic
transfect
cell
indic
inhibitori
effect
bfa
hev
replic
cell
line
depend
also
analys
antivir
activ
bfa
cell
transfect
firefli
luciferas
fluc
subgenom
replicon
figur
bfa
strongli
inhibit
replic
indic
bfa
inhibitori
effect
hev
replic
genotyp
depend
lastli
perform
experi
infecti
clone
shukla
et
al
cell
electropor
strain
rna
bfa
ad
hr
hr
cell
fix
analys
immunofluoresc
capsid
protein
antibodi
shown
figur
treatment
bfa
led
signific
decreas
cell
indic
bfa
inhibit
hev
lifecycl
altogeth
result
demonstr
bfa
inhibit
hev
replic
like
block
cellular
factor
necessari
step
viral
lifecycl
bfa
inhibit
sever
cellular
membran
traffick
pathway
primarili
inhibit
major
cellular
target
member
arf
gef
famili
among
member
arf
gef
famili
human
cell
three
inhibit
bfa
chavrier
gillingham
munro
check
three
gef
requir
hev
replic
analys
effect
deplet
hev
replic
figur
howev
silenc
toxic
experiment
condit
due
slow
kinet
hev
replic
requir
long
deplet
time
altern
use
golgicid
gca
specif
inhibit
effect
et
al
cell
transfect
sirna
pool
target
sirna
pool
figur
two
day
deplet
cell
electropor
replicon
luciferas
activ
measur
hr
pe
describ
previous
shown
figur
deplet
togeth
result
signific
decreas
hev
replic
level
contrast
cell
treat
gca
specif
target
hev
replic
level
strongli
inhibit
figur
without
signific
toxic
figur
altogeth
result
suggest
like
factor
requir
hev
replic
previou
studi
assess
role
hcv
replic
isol
cell
clone
deriv
hepatoma
cell
line
farhat
et
al
cell
line
resist
bfa
abl
support
hcv
replic
presenc
time
bfa
parent
cell
line
resist
due
point
mutat
catalyt
domain
known
impair
bind
bfa
farhat
et
al
order
confirm
bfa
inhibit
hev
replic
relat
effect
drug
transfect
replicon
parent
cell
figur
bfa
ad
hr
previou
experi
hev
replic
strongli
inhibit
bfa
parent
cell
figur
contrast
replic
almost
insensit
bfa
cell
regardless
concentr
bfa
figur
togeth
result
support
conclus
factor
requir
hev
replic
inhibit
hev
replic
due
direct
effect
viru
confirm
host
factor
sensit
bfa
requir
hev
replic
next
use
complement
assay
figur
inde
shown
overexpress
express
mutant
rescu
hcv
replic
bfa
inhibit
wherea
express
catalyt
inact
mutant
farhat
et
al
goueslain
et
al
jackson
casanova
niu
pfeifer
jackson
therefor
transfect
cell
plasmid
express
wildtyp
mutant
inact
mutant
plasmid
express
yfp
protein
use
control
yfp
two
day
express
level
protein
yfp
protein
control
western
blot
figur
fluoresc
microscopi
figur
transfect
infecti
rna
figur
cell
next
treat
hr
ngml
bfa
concentr
inhibit
approxim
hev
replic
note
bfa
treatment
impact
subcellular
localis
protein
figur
four
day
pe
cell
fix
analys
immunofluoresc
capsid
protein
antibodi
describ
figur
transfect
control
dmso
valu
set
correspond
percentag
calcul
bfa
treatment
condit
shown
figur
upon
treatment
bfa
number
cell
reduc
approxim
cell
transfect
yfp
mutant
contrast
overexpress
led
increas
number
cell
express
mutant
restor
hev
replic
compar
dmso
treat
cell
indic
protect
effect
function
overexpress
inhibit
hev
replic
sever
virus
picornavirida
coronavirida
flavivirida
famili
reli
replic
belov
et
al
carpp
roger
moritz
aitchison
goueslain
et
al
lank
et
al
liang
zheng
bao
zhang
qin
et
al
van
der
linden
et
al
verheij
et
al
wang
du
jin
howev
shown
involv
format
polioviru
mous
hepat
coronaviru
hcv
replic
complex
rather
matur
activ
belov
et
al
goueslain
et
al
verheij
et
al
order
investig
involv
hev
replic
next
perform
experi
bfa
ad
hr
variou
time
point
hr
electropor
replic
level
measur
hr
pe
figur
strong
inhibit
hev
replic
bfa
observ
whatev
time
addit
drug
even
bfa
ad
hr
pe
indic
bfa
abl
inhibit
hev
replic
cell
replic
complex
alreadi
form
togeth
result
suggest
requir
activ
hev
replic
complex
assembl
demonstr
cellular
factor
requir
hev
replic
next
analys
subcellular
localis
cell
use
immunofluoresc
confoc
microscopi
figur
due
lack
tool
probe
protein
cell
lenggenhag
et
al
studi
hev
replicas
could
perform
therefor
cell
cell
transfect
infecti
clone
antibodi
direct
capsid
protein
expect
cell
stain
observ
perinuclear
structur
cytoplasm
small
structur
figur
similar
intracellular
distribut
observ
cell
figur
indic
major
subcellular
localis
modifi
upon
hev
replic
therefor
like
recruit
stabli
maintain
hev
replic
complex
result
obtain
transfect
cell
data
shown
altern
approach
determin
whether
recruit
replic
site
analys
subcellular
localis
cell
overexpress
polyprotein
combin
structur
protein
figur
protein
detect
three
differ
antibodi
direct
either
met
hel
pol
domain
observ
differ
localis
upon
express
viral
protein
addit
regardless
antibodi
use
strengthen
hypothesi
probabl
recruit
hev
replic
site
due
difficulti
amplifi
hev
cell
cultur
absenc
tool
analys
hev
protein
mechan
lead
hev
replic
particularli
poorli
understood
site
rna
replic
within
host
cell
identifi
yet
howev
use
vector
system
show
polyprotein
might
localis
ergic
suggest
hev
replic
might
occur
within
earli
secretori
pathway
et
al
studi
show
activ
hev
replic
complex
strongli
depend
gef
regul
activ
arf
small
turn
key
regul
cellular
secretori
pathway
demonstr
bfa
gca
specif
inhibitor
inhibit
hev
replic
cellular
factor
requir
hev
replic
orchestr
retrograd
transport
activ
arf
protein
regul
vesicl
transport
chavrier
also
particip
golgi
morphogenesi
lipid
droplet
metabol
jackson
bouvet
addit
hijack
sever
rna
virus
includ
picornavirida
coronavirida
flavivirida
member
replic
belov
et
al
carpp
et
al
goueslain
et
al
lank
et
al
liang
et
al
qin
et
al
van
der
linden
et
al
verheij
et
al
wang
et
al
instanc
shown
interact
polioviru
coxsackieviru
protein
wessel
et
al
wessel
et
al
overexpress
rescu
enteroviru
replic
cell
treat
bfa
wherea
silenc
strongli
inhibit
viral
replic
belov
et
al
lank
et
al
precis
role
enteroviru
replic
clear
propos
function
would
necessari
enteroviru
replic
recruit
cellular
factor
support
replic
phosphatidylinositol
kinas
hsu
et
al
howev
recent
data
suggest
enteroviru
replic
requir
region
protein
activ
belov
kovtunovych
jackson
ehrenfeld
viktorova
nchoutmboub
belov
contrast
activ
crucial
mous
hepat
coronaviru
rna
replic
verheij
et
al
also
host
factor
requir
hcv
replic
goueslain
et
al
contrast
enterovirus
interact
viral
protein
report
far
addit
shown
recent
role
hcv
replic
mediat
activ
farhat
et
al
interestingli
shown
essenti
mediat
function
hcv
replic
yet
deplet
two
arf
protein
inhibit
secretori
pathway
instead
affect
lipid
metabol
farhat
et
al
studi
demonstr
essenti
function
hev
replic
experi
use
arf
protein
express
knockdown
mutant
catalyt
domain
farhat
et
al
necessari
defin
import
activ
hev
replic
mani
rna
virus
manipul
intern
membran
host
cell
establish
replic
complex
frequent
cytosol
leaflet
remodel
membran
compartmentalis
allow
coordin
differ
step
replic
cycl
result
highli
effici
rna
replic
well
protect
viral
genom
cell
defens
mechan
remodel
membran
characteris
two
differ
type
membran
structur
invagin
vesicl
spherul
type
induc
instanc
dengu
viru
doubl
membran
vesicl
induc
instanc
polioviru
hcv
review
paul
induc
maintain
membran
rearrang
virus
usurp
cellular
factor
activ
membran
instanc
enterovirus
recruit
arf
gef
rearrang
golgi
ergic
membran
belov
et
al
reticulon
protein
tang
et
al
wherea
alphavirus
subvert
amphiphysin
localis
plasma
membran
membran
remodel
viral
rna
replic
neuvonen
et
al
mention
previous
essenti
replic
enterovirus
coronavirus
flavivirus
virus
induc
remodel
intracellular
membran
present
studi
demonstr
cellular
factor
requir
activ
hev
replic
complex
base
fact
virus
use
replic
induc
membran
rearrang
therefor
specul
hev
replic
might
depend
membran
reshuffl
studi
use
electron
microscopi
cell
highli
replic
hev
genom
thu
requir
test
hypothesi
order
determin
whether
recruit
protein
replic
complex
observ
polioviru
protein
wessel
et
al
wessel
et
al
analys
subcellular
distribut
howev
although
protein
domain
protein
detect
antibodi
cell
transfect
vector
system
lenggenhag
et
al
et
al
antibodi
fail
detect
protein
cell
data
shown
lenggenhag
et
al
lack
tool
direct
prevent
us
analys
whether
recruit
replic
complex
cell
indirect
approach
first
analys
subcellular
distribut
hev
replic
cell
found
evid
chang
intracellular
localis
second
altern
approach
studi
subcellular
distribut
cell
overexpress
viral
replicas
found
intracellular
pattern
unaffect
viral
protein
express
addit
find
evid
result
suggest
involv
hcv
replic
might
indirect
role
hev
replic
activ
effector
involv
hev
replic
howev
experi
protein
cell
need
elucid
involv
hev
replic
develop
tool
allow
probe
protein
cell
thu
essenti
characteris
mechan
hev
replic
involv
conclus
result
highlight
function
connect
hev
rna
replic
earli
secretori
pathway
host
cell
identifi
precis
function
hev
replic
potenti
effect
hev
replic
intracellular
membran
also
provid
new
insight
understand
cellular
mechan
underli
hev
rna
replic
dulbecco
modifi
eagl
medium
dmem
phosphat
buffer
salin
pb
foetal
calf
serum
fc
purchas
life
technolog
mowiol
golgicid
calbiochem
proteas
inhibitor
cocktail
complet
roch
sofosbuvir
purchas
selleckchem
houston
usa
chemic
sigma
nakabayashi
taketa
miyano
yaman
sato
blight
mckeat
rice
farhat
et
al
montpelli
et
al
cell
grown
dmem
supplement
mm
inactiv
fc
dmemfc
cell
stabli
express
rna
polymeras
et
al
kindli
provid
volker
lohmann
ralf
bartenschlag
univers
heidelberg
germani
use
transfect
express
vector
plasmid
allow
express
respect
lenggenhag
et
al
rabbit
polyclon
antibodi
met
hel
polymeras
domain
kindli
provid
tero
ahola
univers
helsinki
finland
et
al
mous
mab
antibodi
registri
millipor
mous
mab
roch
rabbit
antibodi
bethyl
laboratori
mous
antibodi
registri
bd
bioscienc
mous
tubulin
sigma
secondari
antibodi
jackson
immunoresearch
cell
cultur
grown
plate
incub
bfa
gca
dmso
hr
incub
time
sofosbuvir
kept
cultur
hr
base
viabil
assay
celltit
aqueou
cell
prolifer
assay
promega
conduct
recommend
manufactur
plasmid
express
cell
cultur
adapt
kernow
strain
genbank
access
number
replicon
express
gaussia
luciferas
gene
provid
u
emerson
shukla
et
al
replicon
construct
use
gener
new
replicon
construct
first
amino
acid
match
signal
peptid
gaussia
luciferas
delet
block
luciferas
secret
fusion
polymeras
chain
reaction
done
extern
primer
intern
primer
strain
replicon
express
firefli
luciferas
describ
previous
pudupakam
et
al
kindli
provid
xj
meng
virginia
polytechn
institut
state
univers
blacksburg
va
cap
rna
transcript
gener
mmessag
kit
ambion
deliv
cell
electropor
use
gene
pulser
apparatu
plasmid
express
yellow
fluoresc
protein
yfp
describ
previous
goueslain
et
al
niu
et
al
well
seed
cell
electropor
rna
drug
bfa
gca
sofosbuvir
ad
hr
pe
kept
h
hr
pe
cell
lyse
buffer
provid
manufactur
promega
gaussia
firefli
luciferas
activ
determin
correspond
luciferas
assay
system
promega
use
tristar
luminomet
berthold
luciferas
activ
hr
pe
use
determin
electropor
effici
rna
interfer
experi
carri
pool
four
differ
synthet
sirna
target
plu
smart
pool
reagent
dharmacon
control
use
studi
plu
sirna
sirna
transfect
lipofectamin
rnai
max
life
technolog
ad
ml
incub
min
plate
sirna
spot
centr
well
case
doubl
sirna
transfect
sirna
use
dilut
transfect
reagent
ad
sirna
mixtur
incub
min
room
temperatur
end
incub
freshli
trypsinis
cell
volum
ml
cultur
medium
ad
transfect
mix
cell
return
two
day
cell
trypsinis
replicon
rna
electropor
describ
previous
cell
seed
plate
transfect
plasmid
express
wild
type
mutant
yfp
protein
reagent
follow
instruct
manufactur
miru
two
day
express
protein
control
western
blot
fluoresc
microscopi
cell
electropor
infecti
rna
cultur
hr
presenc
bfa
ngml
hr
pe
cell
fix
methanol
stain
antibodi
transfect
protein
yfp
cell
valu
adjust
cell
cultur
presenc
dmso
transfect
cell
rins
three
time
cold
pb
lyse
min
buffer
contain
mm
triscl
mm
nacl
mm
ethylenediaminetetraacet
acid
sodium
dodecyl
sulfat
ph
mm
phenylmethylsulfonyl
fluorid
proteas
inhibitor
cocktail
complet
insolubl
materi
remov
centrifug
protein
resolv
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
transfer
onto
nitrocellulos
membran
amersham
use
apparatu
protein
interest
reveal
specif
primari
antibodi
follow
secondari
antibodi
conjug
peroxidas
protein
visualis
use
enhanc
chemiluminesc
ecl
plu
ge
healthcar
signal
record
use
la
apparatu
fujifilm
indirect
immunofluoresc
label
perform
previous
describ
rouill
et
al
nuclei
stain
cell
transfect
rna
stain
mous
mab
posit
cell
count
condit
confoc
microscopi
analys
cell
transfect
rna
antibodi
cell
transfect
combin
met
hel
polymeras
domain
antibodi
author
disclos
conflict
